We are live on ! Find out more
BIO.B icon

Bio-Rad Laboratories Class B
BIO.B

9 hedge funds and large institutions have $14.1M invested in Bio-Rad Laboratories Class B in 2014 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

251% more capital inflows, than outflows

Capital inflows: $28.4K | Capital outflows: $8.07K

13% more funds holding

Funds holding: 8 → 9 (+1)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more ownership

Funds ownership: 2.45% → 2.45% (+0%)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
9
Holders Change
+1
Holders Change %
+12.5%
% of All Funds
0.26%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
1
Increased
1
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
GSC
Ground Swell Capital
South Carolina
+$27.1K
2
UBS
UBS
Switzerland
+$1.31K

Top Sellers

Rank Fund Capital Flow
1
Barclays
Barclays
United Kingdom
-$7.95K
2
Bank of America
Bank of America
North Carolina
-$119

BIO.B Hedge Fund Activity: Q3 2014 in Review

9 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class B (BIO.B) for Q3 2014, worth a combined $14.1M — down 6.2% from $15M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new BIO.B positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 2 trimmed.

The largest buyer was Ground Swell Capital, opening a new position worth an estimated $27.1K. The largest seller was Barclays, cutting an estimated $7.95K.

  • 9 institutional investors held Bio-Rad Laboratories Class B (BIO.B) as of Q3 2014, up from 8 in Q2 2014.
  • Funds reported $14.1M of Bio-Rad Laboratories Class B stock for Q3 2014, down 6.2% quarter-over-quarter.
  • 1 fund opened new Bio-Rad Laboratories Class B positions in Q3 2014 and 0 closed out, a net change of +1 holder.
  • The largest Bio-Rad Laboratories Class B buyer in Q3 2014 was Ground Swell Capital, an estimated $27.1K added.
  • The largest Bio-Rad Laboratories Class B seller in Q3 2014 was Barclays, an estimated $7.95K sold.

Based on aggregated 13F filings for Q3 2014.